Blog
Stämm at the Bio International Convention: Pioneering Continuous Production in Biomanufacturing
Stämm’s Participation We’re still feeling the effects of everything we experienced at the Bio International Convention 2024, and we want to share it with you in this new issue of Stämm Monthly. This crucial event for the biotech industry attracts innovators and leaders from around the globe. It’s the perfect stage to showcase cutting-edge technologies … Stämm at the Bio International Convention: Pioneering Continuous Production in Biomanufacturing
Bioanalytics in Biotech: Bridging R&D and Market Success
Introduction In the biotech industry, the journey from developing novel biological products and therapeutics to bringing them to market is intricate and fraught with regulatory hurdles. Ensuring that products meet stringent regulatory standards such as ISO (International Organization for Standardization), FDA (Food and Drug Administration), and GMP (Good Manufacturing Practices) is crucial. This is where … Bioanalytics in Biotech: Bridging R&D and Market Success
Towards Universal iPSCs: Stämms Take on Autologous Therapies
Autologous therapies, installed capacity, and lab automation: three key concepts we discussed on the latest Swiss Biotech Day. Learn how Stämm participated at the premier biotechnology conference in Europe, talking through the latest in iPSCs-based therapies. The Swiss Biotech Day experience Juan Martin Cabaleiro, Román Ortega Bianchi, and Sebastián de Achaval attended the latest Swiss … Towards Universal iPSCs: Stämms Take on Autologous Therapies
Scaling Up Biomanufacturing: Overcoming Challenges and Driving Innovation
In the landscape of healthcare and pharmaceuticals, scaling up biomanufacturing processes is both a challenge and a crucial endeavor. Industry professionals, researchers, and investors understand how biomanufacturing provides life-saving therapeutics to the market. Nowadays, we have to navigate industry and R&D challenges while uncovering opportunities for innovation. The Challenge of Scaling Up Scaling up industrial … Scaling Up Biomanufacturing: Overcoming Challenges and Driving Innovation
What Fueled Stämm’s Success in Switzerland?
If you read the first article of this newsletter, or you’ve been keeping up with our Linkedin posts, then you probably know that last year our team embarked on a scientific journey. The Bioprocessor, our flagship product, traveled to Switzerland for two months to be demoed by partners outside Stämm. We conducted multiple runs at … What Fueled Stämm’s Success in Switzerland?
Stämm’s Successful Venture at JP Morgan Week: Building Alliances and Sharing Biotech Innovations
From 8 to 11 January, we participated in the JP Morgan Week in San Francisco, where the top players in the biotech industry meet. At the same time, we attended the Biotech Showcase, where we had one-on-one talks with key players. In addition to Yuyo Llamazares Vegh, our co-founder and CEO, our team included Juan … Stämm’s Successful Venture at JP Morgan Week: Building Alliances and Sharing Biotech Innovations
Innovation beyond borders: Our technology thrives in Switzerland’s biotech epicentre
The Bioprocessor, our flagship product, travelled to Switzerland for the last two months to be demoed by partners outside Stämm Biotech. This biotech device takes advantage of microfluidics to miniaturise all bio-manufacturing steps on a single continuous production platform. Two prototypes were exported for verification testing. We conducted multiple runs at the facilities of BioArk, … Innovation beyond borders: Our technology thrives in Switzerland’s biotech epicentre
Learning from alternative organizations: Gemba expedition experience
In April we were part of the Gemba experience together with other companies from Argentina. The event was organized by Liqueed and 10Pines and held in Madrid, Barcelona, and Bilbao, Spain. The goal was to learn about different organization and management styles from more than 10 companies that, supported by the desire to generate a … Learning from alternative organizations: Gemba expedition experience
Charting the Path to the Biotechnological Revolution: Our Journey to Switzerland Fuels Our Growth and Strategic Collaborations
By: Carolina Cárdenas Last April, Román Ortega Bianchi, our BD Leader, and Juan Martín Cabaleiro, our CTO, embarked on a purposeful journey to Switzerland on behalf of our company. One of our key objectives was to attend the Swiss Biotech Day 2023 event in Basel, organized by the Swiss Biotech Association. We participated in engaging … Charting the Path to the Biotechnological Revolution: Our Journey to Switzerland Fuels Our Growth and Strategic Collaborations
Singularity University Colombia’s visit to Stämm and Argentina’s biotech hub
On April 19, 2023, we welcomed Singularity University Colombia in our offices in the context of their visit to Argentina’s biotech ecosystem. We also welcomed Oncoliq, Limay Biosciences, and Bitgenia. We all had the opportunity to present our proposal and highlight our impact. Singularity University focuses on training visionary leaders to harness technology and improve … Singularity University Colombia’s visit to Stämm and Argentina’s biotech hub